Dr. Carolyn Bertozzi’s impact in the field of glycosylation has been profound, enabling on our current understanding of disease and inflammation presentation and potential vehicles for treatment. Dr. Bertozzi was awarded the Nobel Prize in 2024 for the development of biorthogonal chemistry, and she explains how this understanding can impact disease treatment.